Mirai Bio

The first open end-to-end platform for genetic medicines

Cambridge, United States · $50.0M raised

Employees
11–50
Total Funding
$50.0M
Last Round
$50.0M Series ASep 2024
Rounds
1

About

Machine intelligence-based open platform for end-to-end genetic medicine development, enabling delivery to any tissue and cell type.

Summary

Mirai Bio is an Artificial Intelligence company based in Cambridge, United States. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in Sep 2024. Investors include Flagship Pioneering.

Tech & App Stack

2 technologies & apps tracked

Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries ASep 2024
$50.0M

Investors

Similar Companies